Dr. Sweta Lunkad

Speciality: Haematology

Designation: Consultant - Haematology, Haemato-oncology & BMT

  • Pune


Dr. Sweta Lunkad practices as Consultant - Haematologist-Oncologist and Bone Marrow Transplant Physician at Jupiter Hospital, Pune. She has done her Transplant Training in AIIMS, New Delhi and has also done her fellowship in Bone Marrow transplant. She has a vast experience in various kinds of transplants, including Autologous, Allogenic, MUD and haploidentical transplant. She does both adult and pediatric bone marrow transplants. Her centre is an integrated centre of excellence in Haematology, pediatric haematology and bone marrow transplant. Her team specializes in diagnosing, and managing all hematology related condition like thalassemias, aplastic anemias to acute leukemias and chemotherapies.

She has many publications and presentation in many international and national transplant related conferences. Her centre is the best bone marrow transplant centre for diseases like Aplastic anemia, Thalassemia, MDS/Leukemias Lymphomas and Myelomas. She is also one of the few transplant physicians in India who have done transplants for rare diseases like SCID, HLH, Multiple sclerosis, Osteropetrosis. 


  • DNB Resident in Sahyadri Hospital,Pune from 10th August 2012 till 15th March 2013
  • Fellowship in Haematology and Bone marrow Transplant unit in BLK Super Specialty Hospital, New Delhi from April 2013 to April 2016.
  • Post graduate - Senior Resident in Department of Clinical Hematology at All India Institute of Medical Sciences (AIIMS) New Delhi from July 2016 – till July 2019
She specializes in clinical hematology and bone marrow transplant.Her areas of interest include pediatric hematology, including benign diseases like thalassemia, sickle cell anemia, Aplastic anemia to malignant diseases like acute leukemia. She also excels in management of Acute and chronic Leukemias, MDS, Lymphomas and myelomas.
Permanent member of Indian society of Transfusion and Haematology
  • Epidemiology of co existence of Diabetes and hypertension in railway population” as a Post graduate Dissertation. Accepted in 2010
  • Reversible Posterior Leukoencephalopathy Syndrome In A Case Of Adult Onset Still's Disease With Concurrent Thrombotic Thrombocytopenic Purpura: Response To High Dose Immunoglobulin Infusions; JAPI • November 2012 • VOL. 60
  • Haploidentical Haematopoietic Stem Cell Transplant for Thalassaemia Major Using pre transplant immunosupression and Post Transplant Cyclophosphamide; EBMT16-PH-2014
  • Awarded with “Doctor Of Month” award at Dr.B.L.Kapur Hopsital Delhi in 2015.
  • Presented a poster titeled “Haploidentical hematopoietic stem cell transplant for thalassaemia major using fludarabine - busulphan- thymoglobulin and post transplant cyclophosphamide: early experience”; APBMT2016-ABS-190 at Okinava, Japan.
  • Presented a poster titeled “Bone marrow transplant for recessive dystrophic epidermolysis bullosa: a case report; APBMT2016-ABS-216” at Okinava, Japan.
  • Peripheral Blood Stem Cell Collection on Day 4 Is Feasible and Safe in a Majority of Allogeneic Stem Cell Transplant Donors; 2016 BMT Tandem Meetings
  • Hematopoietic Stem Cell transplant in Elderly Patients: Experience from a tertiary care centre in Northern India; Indian J Hematol Blood Transfus DOI 10.1007/s12288-015-0624-0
  • Day 4 Peripheral Blood Stem Cell Collection in Myeloma Patients is Feasible and and Cost-effective in a Majority of Patients, 15th International Myeloma Workshop Rome, September 23-26, 2015
  • An Unusual Cause of Anemia and Encephalopathy; Mediterr J Hematol Infect Dis www.mjhid.org 2015;
  • Renal Involvement in Multiple Myeloma, ISHBT-EHA; Eposter
  • To determine if colonization of gut with carbapenem resistant enterobacteriaceae in surveillance cultures affect the outcome of high risk febrile neutropenic patients”; EHA-1397; EHA 2018
  • Presented a poster titled “ Gut colonization with carbapenem resistant enterobacteriaceae leads to more chemotherapy interruptions and higher mortality in patient with acute leukemia receiving remission induction chemotherapy”; ASH-4002; ASH 2018 at San Diago, USA which was given a travel grant by ICMR (Indian council of Medical research ) New Delhi.
  • “To determine if colonization of gut with carbapenamase resistant enterobacteriaceae in surveillance culture affects the outcome of high risk febrile neutropenic patients” as a DM research project , Submitted to AIIMS in Jan 2019.

Awards/Honours: Awarded the prestigious ICMR grant in 2018 for presenting in American Society of Hematology

Day: Monday/Tuesday/Thursday/Friday/Saturday
Timing: 10:00 to 12:00 / 14:00 to 16:00
* Timings are subjected to change in case of emergency & unforeseen situations.

Book an Appointment